Chitosan-polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: in vitro evaluation.
about
Development and characterization of chitosan-polycarbophil interpolyelectrolyte complex-based 5-fluorouracil formulations for buccal, vaginal and rectal application.Minocycline hydrochloride nanoliposomes inhibit the production of TNF-α in LPS-stimulated macrophages.The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.Comparison of the in vitro release characteristics of mucosal freeze-dried wafers and solvent-cast films containing an insoluble drug.Spray drying formulation of albendazole microspheres by experimental design. In vitro-in vivo studies.
P2860
Chitosan-polycarbophil interpolyelectrolyte complex as a matrix former for controlled release of poorly water-soluble drugs I: in vitro evaluation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Chitosan-polycarbophil interpo ...... drugs I: in vitro evaluation.
@en
Chitosan-polycarbophil interpo ...... drugs I: in vitro evaluation.
@nl
type
label
Chitosan-polycarbophil interpo ...... drugs I: in vitro evaluation.
@en
Chitosan-polycarbophil interpo ...... drugs I: in vitro evaluation.
@nl
prefLabel
Chitosan-polycarbophil interpo ...... drugs I: in vitro evaluation.
@en
Chitosan-polycarbophil interpo ...... drugs I: in vitro evaluation.
@nl
P2860
P1476
Chitosan-polycarbophil interpo ...... drugs I: in vitro evaluation.
@en
P2093
Weiyang Chen
P2860
P304
P356
10.3109/03639040903315579
P407
P577
2010-05-01T00:00:00Z